FDA approves Biogen’s aducanumab
Aduhelm (aducanumab) is the first new dementia drug treatment to come to market since 2003.
News & events
News, conferences, events, blogs and updates from across the field of dementia and the work of Alzheimer's Disease International.
Featured news and events
Life in a dementia care centre during India’s second COVID-19 wave: Part one
In this four part series, Senju Joseph, a carer at the Dementia Respite care centre in Thrissur, India, documents his experience of navigating the catastrophic second COVID-19 wave.
World Alzheimer Report 2020: Design, Dignity, Dementia: dementia-related design and the built environment
Alzheimer’s Disease International (ADI) launches the world’s most comprehensive report on dementia-related design and the built environment.
Dementia design 30 years behind, condition must be recognised as disability
Dementia design in built environment is 30 years behind physical disabilities movement ADI calls on governments to embed design in their national dementia responses under the Convention on the Rights for Persons with Disabilities Dementia design follows simple principles, is cost effective and dramatically improves enjoyment and safety of built environment…
China adopts a national dementia plan
A national dementia plan for China has been officially launched as a part of China’s Action Plan for Healthy China 2030.
COVID-19 deaths disproportionately affecting people with dementia, targeted response urgently needed
Press release on COVID-19 deaths and dementia
COVID-19 deaths disproportionately affecting people with dementia
At the beginning of World Alzheimer's Month, ADI highlights evidence that the COVID-19 pandemic is leading to extremely high death rates amongst people with dementia globally.
Are health systems ready for new Alzheimer’s diagnostics and treatments?
Two new reports highlight the challenges faced by health systems in the United States and five European countries to ensure preparedness for potentially imminent Alzheimer’s biomarker and treatment breakthroughs.
The Lancet launches important new guidance on dementia risk reduction
The Lancet launches new guidance which reveals that an extended set of 12 modifiable risk factors might prevent or delay up to 40 per cent of dementia cases globally.
Dominican Republic adopts a national dementia plan
The Dominican Republic’s Ministry of Public Health announces that the country will be launching a national dementia plan.